Cargando…

Iron deficiency and cardiovascular disease

Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients with coronary artery disease, and an even higher proportion of those with heart failure (HF) or pulmonary hypertension have ID; the evidence for cerebrovascular disease, aortic stenosis and atrial fibrillat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savarese, Gianluigi, von Haehling, Stephan, Butler, Javed, Cleland, John G F, Ponikowski, Piotr, Anker, Stefan D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805408/ https://www.ncbi.nlm.nih.gov/pubmed/36282723 http://dx.doi.org/10.1093/eurheartj/ehac569

Ejemplares similares

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020)

Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
por: Qiu, Chengxuan, et al.
Publicado: (2009)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2023)

Climate change and the prevention of cardiovascular disease
por: Jacobsen, Alan P., et al.
Publicado: (2022)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

Immunometabolism at the Heart of Cardiovascular Disease
por: DeBerge, Matthew, et al.
Publicado: (2023)

Cerebral aging: integration of brain and behavioral models of cognitive function
por: Park, Denise C., et al.
Publicado: (2001)

Therapeutic Genome Editing in Cardiovascular Diseases
por: German, David M., et al.
Publicado: (2019)

Epidemiological Features of Cardiovascular Disease in Asia
por: Zhao, Dong
Publicado: (2021)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Psychiatric manifestations of neurologic disease: where are we headed?
por: Lyketsos, Constantin G., et al.
Publicado: (2007)

Mental disorders in primary care
por: Wittchen, Hans-Ulrich, et al.
Publicado: (2003)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Single-cell technologies to decipher cardiovascular diseases
por: Abplanalp, Wesley Tyler, et al.
Publicado: (2022)

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
por: Raman, Betty, et al.
Publicado: (2022)

Alzheimer's disease
por: Schachter, Armand S., et al.
Publicado: (2000)

Designer Approaches for G Protein–Coupled Receptor Modulation for Cardiovascular Disease
por: Grisanti, Laurel A., et al.
Publicado: (2018)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Sleep-disordered breathing and cardiovascular disease
por: Anker, Stefan D., et al.
Publicado: (2016)

Innate Immune Receptors, Key Actors in Cardiovascular Diseases
por: Jaén, Rafael I., et al.
Publicado: (2020)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
por: Arafa, Ahmed, et al.
Publicado: (2021)

Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
por: Robinson, Emma Louise, et al.
Publicado: (2022)

Small non-coding RNA therapeutics for cardiovascular disease
por: Shah, Ajay M, et al.
Publicado: (2022)

Summarizing 2019 in Cardiovascular Prevention using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach
por: Feldman, David I., et al.
Publicado: (2020)

Ten things to know about ten cardiovascular disease risk factors
por: Bays, Harold E., et al.
Publicado: (2021)

Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease( )
por: van Smeden, Maarten, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Calcium Buffering in the Heart in Health and Disease
por: Smith, Godfrey L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lemhfqjtvg88ic2oi7dqa4pr3g